285 related articles for article (PubMed ID: 29351735)
1. Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values.
Pötschger U; Heinzl H; Valsecchi MG; Mittlböck M
BMC Med Res Methodol; 2018 Jan; 18(1):14. PubMed ID: 29351735
[TBL] [Abstract][Full Text] [Related]
2. Weighted pseudo-values for partly unobserved group membership in paediatric stem cell transplantation studies.
Mittlböck M; Pötschger U; Heinzl H
Stat Methods Med Res; 2022 Jan; 31(1):76-86. PubMed ID: 34812663
[TBL] [Abstract][Full Text] [Related]
3. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
4. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
Schaubel DE; Wei G
Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
[TBL] [Abstract][Full Text] [Related]
5. Assessment of gastric cancer survival: using an artificial hierarchical neural network.
Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A
Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods for estimating the attributable risk in the context of survival analysis.
Gassama M; Bénichou J; Dartois L; Thiébaut AC
BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
[TBL] [Abstract][Full Text] [Related]
7. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
8. Comparison of baseline covariate adjustment methods for restricted mean survival time.
Hanada K; Moriya J; Kojima M
Contemp Clin Trials; 2024 Mar; 138():107440. PubMed ID: 38228232
[TBL] [Abstract][Full Text] [Related]
9. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry.
Bonser RS; Taylor R; Collett D; Thomas HL; Dark JH; Neuberger J;
Lancet; 2012 Aug; 380(9843):747-55. PubMed ID: 22647758
[TBL] [Abstract][Full Text] [Related]
10. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
11. Stagewise pseudo-value regression for time-varying effects on the cumulative incidence.
Zöller D; Schmidtmann I; Weinmann A; Gerds TA; Binder H
Stat Med; 2016 Mar; 35(7):1144-58. PubMed ID: 26510388
[TBL] [Abstract][Full Text] [Related]
12. Landmark cure rate models with time-dependent covariates.
Shi H; Yin G
Stat Methods Med Res; 2017 Oct; 26(5):2042-2054. PubMed ID: 28627311
[TBL] [Abstract][Full Text] [Related]
13. A note on including time-dependent covariate in regression model for competing risks data.
Latouche A; Porcher R; Chevret S
Biom J; 2005 Dec; 47(6):807-14. PubMed ID: 16450853
[TBL] [Abstract][Full Text] [Related]
14. Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma.
Pezzi A; Cavo M; Biggeri A; Zamagni E; Nanni O
BMC Med Res Methodol; 2016 Nov; 16(1):150. PubMed ID: 27829371
[TBL] [Abstract][Full Text] [Related]
15. Pseudo-observations in survival analysis.
Andersen PK; Perme MP
Stat Methods Med Res; 2010 Feb; 19(1):71-99. PubMed ID: 19654170
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
Beyersmann J; Schumacher M
Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
[TBL] [Abstract][Full Text] [Related]
17. Partly conditional survival models for longitudinal data.
Zheng Y; Heagerty PJ
Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
[TBL] [Abstract][Full Text] [Related]
18. The importance of censoring in competing risks analysis of the subdistribution hazard.
Donoghoe MW; Gebski V
BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
[TBL] [Abstract][Full Text] [Related]
19. Regression models for the restricted residual mean life for right-censored and left-truncated data.
Cortese G; Holmboe SA; Scheike TH
Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
[TBL] [Abstract][Full Text] [Related]
20. Impact of censoring on learning Bayesian networks in survival modelling.
Stajduhar I; Dalbelo-Basić B; Bogunović N
Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
